Cara Therapeutics Inc (CARA)
0.7601
+0.03
(+3.68%)
USD |
NASDAQ |
May 09, 16:00
0.7601
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Cash from Operations (TTM): -92.08M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -92.08M |
September 30, 2023 | -98.22M |
June 30, 2023 | -103.76M |
March 31, 2023 | -87.82M |
December 31, 2022 | -78.73M |
September 30, 2022 | -56.46M |
June 30, 2022 | -45.39M |
March 31, 2022 | -61.89M |
December 31, 2021 | -60.09M |
September 30, 2021 | 23.25M |
June 30, 2021 | 15.74M |
March 31, 2021 | 9.095M |
December 31, 2020 | -5.487M |
September 30, 2020 | -118.74M |
June 30, 2020 | -122.76M |
March 31, 2020 | -120.00M |
December 31, 2019 | -109.22M |
September 30, 2019 | -102.42M |
June 30, 2019 | -97.28M |
March 31, 2019 | -31.36M |
December 31, 2018 | -22.30M |
Date | Value |
---|---|
September 30, 2018 | -9.353M |
June 30, 2018 | 1.288M |
March 31, 2018 | -51.66M |
December 31, 2017 | -54.83M |
September 30, 2017 | -56.60M |
June 30, 2017 | -59.65M |
March 31, 2017 | -59.18M |
December 31, 2016 | -47.38M |
September 30, 2016 | -38.36M |
June 30, 2016 | -33.28M |
March 31, 2016 | -26.07M |
December 31, 2015 | -21.48M |
September 30, 2015 | -23.13M |
June 30, 2015 | -19.81M |
March 31, 2015 | -19.79M |
December 31, 2014 | -17.64M |
September 30, 2014 | -16.88M |
June 30, 2014 | -15.84M |
March 31, 2014 | 1.557M |
December 31, 2013 | 2.829M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-122.76M
Minimum
Jun 2020
23.25M
Maximum
Sep 2021
-69.07M
Average
-87.82M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Nektar Therapeutics | -192.61M |
Stereotaxis Inc | -9.139M |
Cerus Corp | -32.71M |
Avid Bioservices Inc | 12.68M |
Rigel Pharmaceuticals Inc | -5.743M |